Form 4: Procore Technologies CEO Craig Courtemanche Jr. Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Procore Technologies CEO Craig Courtemanche Jr. executed multiple sales of common stock on June 3, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Craig F. Courtemanche Jr., CEO and President of Procore Technologies, Inc., reported the sale of common stock on June 3, 2024.
- The sales were executed under a 10b5-1 trading plan established on June 7, 2023.
- Multiple transactions occurred at varying weighted average prices, ranging from $65.75 to $67.71 per share.
- Courtemanche sold shares directly and indirectly through family trusts.
- Following the reported transactions, Courtemanche continues to hold a significant amount of Procore common stock both directly and indirectly.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing plan. It doesn't inherently indicate positive or negative sentiment about the company's future.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on current inside information. Investors often monitor insider transactions for signals about a company's prospects, but sales under a 10b5-1 plan are generally viewed as less informative.
Key Dates
| Date | Description |
|---|---|
| November 1, 2012 | Date of the Craig F. Courtemanche and Hillary Courtemanche Family Trust |
| June 7, 2023 | Date of the 10b5-1 trading plan |
| June 3, 2024 | Date of the reported stock sales |
| June 5, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.